Income Statement

CYTEK BIOSCIENCES, INC.

CTKB
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY
Revenue
201.49 200.45 193.02 164.04 127.95
Cost of Revenue
97.03 89.35 83.59 63.06 48.81
Gross Profit
104.46 111.11 109.43 100.97 79.14
Operating Expenses
144.84 131.63 137.27 102.78 69.99
Research & Development
36.47 39.40 44.15 34.86 24.44
Selling, General & Administrative
58.94 49.11 49.15 34.69 24.71
Other Operating Expenses
- - - - -
Operating Income
-40.38 -20.52 -27.85 -1.80 9.16
Non-Operating Income
10.54 14.82 12.14 3.06 -3.22
Interest Income
2.22 5.12 6.41 4.62 0.05
Interest Expense
- - 2.07 2.57 1.74
Other Non-Op Income / Expense
8.80 4.46 7.79 0.04 0.04
Income Before Tax
-29.84 -5.70 -15.71 1.26 5.94
Income Tax Expense
36.70 0.32 -3.56 -1.22 2.91
Non-Controlling Interest
0.00 0.00 0.00 0.09 0.03
Net Income
-66.54 -6.02 -12.15 2.48 3.03
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY
Depreciation & Amortization
- - - - -
EBITDA
-32.81 -13.31 -21.80 0.69 10.40
Earnings Per Share (Basic)
- - -0.09 0.02 0.00
Diluted EPS
- - -0.09 0.02 0.00
Weighted Average Shares
127.75 130.61 135.28 134.51 76.74
Diluted Weighted Avg Shares
127.75 130.61 135.28 138.56 81.54
Comprehensive Income
-64.31 -4.73 -12.73 0.89 3.86